Manifestations of Perihepatic Lymph Nodes in Acute Flare of Chronic Hepatitis B: Association with HBeAg Status and with HBeAg Seroconversion
暂无分享,去创建一个
H. Kuo | M. Sheu | I. Feng | Yu‐Min Lin | L. Koay | C. Ho | Yen-Ling Ko | K. Chung | Ching‐Yih Lin | Chi‐Shu Sun | Chi‐Shu Sun
[1] J. Shu,et al. Chronic hepatitis B: Enlarged perihepatic lymph nodes correlated with hepatic histopathology. , 2013, World journal of radiology.
[2] Z. Tian,et al. Characterization of the liver-draining lymph nodes in mice and their role in mounting regional immunity to HBV , 2013, Cellular and Molecular Immunology.
[3] Ding‐Shinn Chen,et al. Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation. , 2012, The Journal of infectious diseases.
[4] G. McCaughan,et al. Two lymph nodes draining the mouse liver are the preferential site of DC migration and T cell activation. , 2012, Journal of hepatology.
[5] Zhi‐hua Liu,et al. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B. , 2012, Journal of hepatology.
[6] EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. , 2012, Journal of hepatology.
[7] H. Kuo,et al. The early on-treatment perihepatic lymph node response predicts sustained viral response of anti-hepatitis C virus therapy , 2011, European journal of gastroenterology & hepatology.
[8] Antonio Bertoletti,et al. A longitudinal analysis of innate and adaptive immune profile during hepatic flares in chronic hepatitis B. , 2010, Journal of hepatology.
[9] H. Hsu,et al. Serum levels of interleukin-10 and interleukin-12 predict early, spontaneous hepatitis B virus e antigen seroconversion. , 2010, Gastroenterology.
[10] W. Shin,et al. Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B. , 2009, Gastroenterology.
[11] D. Vassilopoulos,et al. Cellular immune responses in hepatitis B virus e antigen negative chronic hepatitis B , 2008, Journal of viral hepatitis.
[12] G. Fattovich,et al. Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years , 2007, Gut.
[13] C. Chu,et al. Chronic hepatitis B virus infection acquired in childhood: special emphasis on prognostic and therapeutic implication of delayed HBeAg seroconversion , 2007, Journal of viral hepatitis.
[14] H. Kuo,et al. Enlarged lymph nodes in porta hepatis: Sonographic sign of chronic hepatitis B and C infections , 2006, Journal of clinical ultrasound : JCU.
[15] E. Telemo,et al. Induction of antigen‐specific regulatory T cells in the liver‐draining celiac lymph node following oral antigen administration , 2005, Immunology.
[16] M. Yuen,et al. Longitudinal Study of Hepatitis Activity and Viral Replication before and after HBeAg Seroconversion in Chronic Hepatitis B Patients Infected with Genotypes B and C , 2004, Journal of Clinical Microbiology.
[17] C. Chu,et al. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels. , 2004, The American journal of medicine.
[18] Ding‐Shinn Chen,et al. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers , 2004, Journal of medical virology.
[19] E. Jouve,et al. Lymph node enlargement within the hepatoduodenal ligament in patients with chronic hepatitis C reflects the immunological cellular response of the host. , 2003, Journal of hepatology.
[20] Chien-Jen Chen,et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. , 2002, The New England journal of medicine.
[21] H. Chiou,et al. Long‐term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B , 2002, Hepatology.
[22] M. Choi,et al. Clinical Significance of Enlarged Perihepatic Lymph Nodes in Chronic Hepatitis B , 2001, Journal of clinical gastroenterology.
[23] M. Soresi,et al. Evaluation by ultrasound of abdominal lymphadenopathy in chronic hepatitis C , 1999, American Journal of Gastroenterology.
[24] Ding‐Shinn Chen,et al. Hepatitis B Virus Infection , 2007 .
[25] M. Levrero,et al. Ultrasound detection of abdominal lymphadenomegaly in subjects with hepatitis C virus infection and persistently normal transaminases: a predictive index of liver histology severity. , 1998, Journal of hepatology.
[26] Y. Okada,et al. Lymph nodes in the hepatoduodenal ligament: US appearances with CT and MR correlation. , 1996, Clinical radiology.
[27] J. Sung,et al. Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. , 1992, The Journal of clinical investigation.
[28] Chien-Jen Chen,et al. Effects of hepatitis B virus, alcohol drinking, cigarette smoking and familial tendency on hepatocellular carcinoma , 1991, Hepatology.
[29] M. Zoli,et al. Prevalence and Significance of Abdominal Lymphadenopathy in Patients with Chronic Liver Disease: An Ultrasound Study , 1990, Journal of clinical gastroenterology.
[30] A. Lok,et al. Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology. , 1990, Journal of hepatology.
[31] T. Ezaki,et al. The liver lymphatics as a migratory pathway of macrophages from the sinusoids to the celiac lymph nodes in the rat. , 1990, Archives of histology and cytology.
[32] J. Rodés,et al. Analysis of factors predicting early seroconversion to anti-HBe in HBeAg-positive chronic hepatitis B. , 1988, Journal of hepatology.
[33] A. Lok,et al. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. , 1987, Gastroenterology.
[34] J. Hoofnagle,et al. Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis , 1987, Hepatology.
[35] C. Chu,et al. Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. , 1987, Gastroenterology.
[36] J. Hoofnagle,et al. Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis. , 1985, Gastroenterology.
[37] H. Thomas,et al. Natural history of chronic hepatitis B virus infection in taiwan: Studies of hepatitis B virus DNA in serum , 1985, Hepatology.
[38] C. Chu,et al. Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis. , 1983, Gastroenterology.
[39] J. Hoofnagle,et al. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. , 1981, Annals of internal medicine.
[40] M. Rugge,et al. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. , 1980, Gastroenterology.
[41] S. Sherlock,et al. Cellular immunity and hepatitis-associated, Australia antigen liver disease. , 1972, Lancet.